RxDoctor Payments Data

Diogenes Almonte, MD

Pediatrics · Brooklyn, NYNPI 1861606014

Payments from drug & device makers

$1,822in general payments, 2019–2025

Across 83 payments — averaging $21.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$454
  • Lilly USA, LLC$376
  • Astellas Pharma US Inc$164
  • AbbVie$157
  • Exact Sciences$110
  • Amgen$92
  • plus $469 from 14 others

What the payments were for

  • Food & beverage$1,822100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,822 in reported general payments places this provider in the 90th percentile of 4,055 pediatrics providers in New York.

See all pediatrics providers in New York

Medicare billing

Part B allowed, 2024
$63,314
Medicare patients
84
Services billed
648

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate77$67,641
JanumetSitagliptin Phos/Metformin Hcl52$39,285
JardianceEmpagliflozin36$33,166
FarxigaDapagliflozin Propanediol31$31,373
EliquisApixaban26$18,616
VascepaIcosapent Ethyl64$17,240
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$9,932
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$8,360
Albuterol Sulfate HfaAlbuterol Sulfate173$6,490
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate22$3,665
ShingrixVaricella-Zoster Ge/As01b/Pf14$2,875
Atorvastatin Calcium216$2,325
Wixela InhubFluticasone Propion/Salmeterol16$1,903
Metoprolol Succinate110$1,781
Acarbose63$1,615

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet$38$106,926129 claims
AstraZenecaFarxiga, Breztri Aerosphere$454$39,73342 claims
Boehringer IngelheimJardiance$15$33,16636 claims
PfizerEliquis$46$18,61626 claims
GSKTrelegy Ellipta, Shingrix$48$12,80729 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,055 pediatrics providers in New York.

Other pediatrics in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →